Literature DB >> 11909012

Effects of an inadvertent dose of cytarabine in a child with Fanconi's anemia: reducing medication errors.

Michael E Trigg1, Vinay Nadkarni, Aaron Chidekel, Charles McKay, Rita Meek, Gregory Griffin, Maureen Edelson, Anne Reilly, Joseph Peoples, Stuart Levine, Frederick Meier.   

Abstract

We report the case of a 7-year-old boy with Fanconi's anemia, who underwent a bone marrow transplant using an unrelated donor, and who received an inadvertent dose of cytarabine (cytosine arabinoside). The cytarabine was given by mistake 6 months following transplant. This caused excessive toxicity to many systems, including the pulmonary and renal systems. The patient recovered from the episode, but this article further highlights the acute adverse effects of cytarabine. Furthermore, it is the first report of excessive toxicity to cytarabine in a child with Fanconi's anemia. The article also highlights the problems of medication administration errors, particularly in those exquisitely sensitive to the effects of toxic drugs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11909012     DOI: 10.2165/00128072-200204030-00007

Source DB:  PubMed          Journal:  Paediatr Drugs        ISSN: 1174-5878            Impact factor:   3.022


  23 in total

Review 1.  Potentially remediable features of the medication-use environment in the United States.

Authors:  S Hennessy
Journal:  Am J Health Syst Pharm       Date:  2000-03-15       Impact factor: 2.637

2.  Reducing medication errors.

Authors:  B Orser
Journal:  CMAJ       Date:  2000-04-18       Impact factor: 8.262

3.  Research on drug-use-system errors.

Authors:  K N Barker; E L Allan
Journal:  Am J Health Syst Pharm       Date:  1995-02-15       Impact factor: 2.637

4.  Medication errors: learn from your colleagues' mistakes.

Authors:  L J Gobis
Journal:  RN       Date:  1995-12

Review 5.  Fanconi anemia and novel strategies for therapy.

Authors:  J M Liu; M Buchwald; C E Walsh; N S Young
Journal:  Blood       Date:  1994-12-15       Impact factor: 22.113

Review 6.  Bone marrow transplantation for Fanconi anemia.

Authors:  E Gluckman; R Berger; J Dutreix
Journal:  Semin Hematol       Date:  1984-01       Impact factor: 3.851

7.  Ophthalmological and other toxicities related to cytosine arabinoside and total body irradiation as preparative regimen for bone marrow transplantation.

Authors:  W R Vogler; E F Winton; L T Heffner; D S Gordon; P Sternberg; I Crocker; R Reynolds; C K Dobbs
Journal:  Bone Marrow Transplant       Date:  1990-12       Impact factor: 5.483

8.  Morbidity and mortality of open lung biopsy in children.

Authors:  L Davies; S Dolgin; M Kattan
Journal:  Pediatrics       Date:  1997-05       Impact factor: 7.124

9.  Successful bone marrow transplant for Fanconi's anaemia.

Authors:  A J Barrett; W D Brigden; J R Hobbs; K Hugh-Jones; J G Humble; D C James; S Retsas; T R Rogers; S Selwyn; P Sneath; J G Watson
Journal:  Br Med J       Date:  1977-02-12

10.  Fatal cardiac toxicity in bone marrow transplant patients receiving cytosine arabinoside, cyclophosphamide, and total body irradiation.

Authors:  M E Trigg; J L Finlay; M Bozdech; E Gilbert
Journal:  Cancer       Date:  1987-01-01       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.